POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 74 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,220,500 | +35.2% | 5,975,000 | 0.0% | 0.08% | +4.1% |
| Q2 2023 | $10,516,000 | -42.9% | 5,975,000 | 0.0% | 0.07% | -59.0% |
| Q1 2023 | $18,403,000 | -41.9% | 5,975,000 | 0.0% | 0.18% | -68.0% |
| Q4 2022 | $31,667,500 | +50.1% | 5,975,000 | 0.0% | 0.56% | +135.6% |
| Q3 2022 | $21,092,000 | +64.6% | 5,975,000 | +20.3% | 0.24% | +56.3% |
| Q2 2022 | $12,815,000 | -42.4% | 4,967,227 | 0.0% | 0.15% | -43.2% |
| Q1 2022 | $22,253,000 | -34.2% | 4,967,227 | 0.0% | 0.27% | -27.7% |
| Q4 2021 | $33,827,000 | -6.6% | 4,967,227 | 0.0% | 0.37% | 0.0% |
| Q3 2021 | $36,211,000 | -27.2% | 4,967,227 | 0.0% | 0.37% | -10.5% |
| Q2 2021 | $49,772,000 | +4.9% | 4,967,227 | 0.0% | 0.41% | -9.3% |
| Q1 2021 | $47,437,000 | -12.9% | 4,967,227 | 0.0% | 0.45% | -31.2% |
| Q4 2020 | $54,490,000 | +25.9% | 4,967,227 | +1.8% | 0.66% | +17.5% |
| Q3 2020 | $43,281,000 | – | 4,879,490 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |